Home/Filings/4/0001181431-14-013028
4//SEC Filing

INVIVO THERAPEUTICS HOLDINGS CORP. 4

Accession 0001181431-14-013028

CIK 0001292519operating

Filed

Mar 16, 8:00 PM ET

Accepted

Mar 17, 5:05 PM ET

Size

8.2 KB

Accession

0001181431-14-013028

Insider Transaction Report

Form 4
Period: 2014-03-13
REYNOLDS FRANCIS
DirectorCEO, CFO10% Owner
Transactions
  • Sale

    Common Stock

    2014-03-14$2.47/sh12,500$30,8759,673,920 total
  • Sale

    Common Stock

    2014-03-17$2.48/sh12,500$31,0009,661,420 total
  • Sale

    Common Stock

    2014-03-13$2.37/sh12,500$29,6259,686,420 total
Holdings
  • Common Stock

    (indirect: By 401(k))
    23,488
Footnotes (3)
  • [F1]All sales between $2.30 - $2.43.
  • [F2]All sales between $2.40 - $2.56.
  • [F3]All sales between $2.42 - $2.53.

Issuer

INVIVO THERAPEUTICS HOLDINGS CORP.

CIK 0001292519

Entity typeoperating
IncorporatedNV

Related Parties

1
  • filerCIK 0001292519

Filing Metadata

Form type
4
Filed
Mar 16, 8:00 PM ET
Accepted
Mar 17, 5:05 PM ET
Size
8.2 KB